Chandler Robinson
Vermögen: 10 Mio $ am 31.05.2026
Vermögen: 10 Mio $ am 31.05.2026
Chandler Drew Robinson is the founder of Monopar Therapeutics, Inc., founded in 2014, serving as President, Chief Executive Officer & Director.
Dr. Robinson is the founder of Tactic Pharma LLC, founded in 2010, serving as Manager.
Dr. Robinson currently serves as Director at the Chemistry of Life Processes Institute.
Former positions include Director at Wilson Therapeutics AB, Director at Wilson Therapeutics, Inc., Co-Manager-Healthcare Clinic at Onyx Pharmaceuticals, Inc., and President at The Bear Stearns Cos.
LLC.
Education includes a doctorate from Stanford University, an MBA from the University of Cambridge, an undergraduate degree from Northwestern University, and a graduate degree from the London School of Economics & Political Science.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MONOPAR THERAPEUTICS INC 2,29 % | 31.03.2026 | 153.293 ( 2,29 % ) | 10 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Gründer | 01.12.2014 |
Chemistry of Life Processes Institute
Chemistry of Life Processes Institute Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Tactic Pharma LLC
Tactic Pharma LLC Miscellaneous Commercial ServicesCommercial Services Develops pre-clinical and clinical stage compounds | Gründer | 01.01.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
The Bear Stearns Cos. LLC
The Bear Stearns Cos. LLC Investment Banks/BrokersFinance Provides investment banking and securities dealing services | Präsident | - |
Wilson Therapeutics, Inc. | Direktor/Vorstandsmitglied | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | - |
| WILSON THERAPEUTICS AB | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
The Bear Stearns Cos. LLC
The Bear Stearns Cos. LLC Investment Banks/BrokersFinance Provides investment banking and securities dealing services | Finance |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wilson Therapeutics AB
Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company focusing in treatment of Wilson disease | Health Technology |
Monopar Therapeutics, Inc.
Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Wilson Therapeutics, Inc. | |
Chemistry of Life Processes Institute
Chemistry of Life Processes Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tactic Pharma LLC
Tactic Pharma LLC Miscellaneous Commercial ServicesCommercial Services Develops pre-clinical and clinical stage compounds | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen